The July edition of the Journal is now available online and includes: Venous thromboembolism and COCs: an ongoing saga This ongoing controversy recently resulted in the decision of the French authorities to withdraw the combined oral contraceptive (COC) containing ethinylestradiol (EE) and cyproterone acetate (i.e. Diane 35®) from the market. This consensus statement from 26 […]
Category: News
New injectable – Sayana Press and Dianette VTE update
Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]
Sexual health improvement framework, comments and other News
‘A Framework for Sexual Health Improvement in England’ sets out the government’s ambitions for improving sexual health. Designed to be used by local organisations when they are looking at how best to provide sexual health services in their area. This includes the need for: a fall in the number of unwanted pregnancies greater efforts to […]
Depo-Provera does not increase fracture risk.
Results from a new study published in the March issue of Obstetrics and Gynaecology demonstrate that the use of depot medroxyprogesterone acetate (DMPA) does not appear to increase fracture risk. Whilst the use of DMPA reduces serum oestrogen levels and is associated with significant loss of bone mineral density (BMD), this study shows that it […]
JFPRHC is looking for a dynamic reader to take on the role of social media editor The Journal already has a strong readership and offers online features such as a blog, podcasts, Facebook and Twitter. This new post has been created to assist the editorial team in improving the journal’s interactivity and web presence via […]
Press Releases: Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause & Cuts to services set to cost UK £136.7 billion
Risk of Unwanted Pregnancies with Morning After Pill Conscience Clause This article is published in the Journal of Medical Ethics today – “The Fox and the grapes: an Anglo-Irish perspective on conscientious objection to the supply of emergency hormonal contraception without prescription” Conscience clauses, which allow pharmacists to opt out of providing the “morning after […]
SRH News
Education for Choice hightlights misleading pregnancy counselling Education for Choice support young people’s right to informed choice on abortion. They report that Feminist Action Cambridge held a demo in Cambridge city centre to raise awareness of local ‘crisis pregnancy centres’ which they feel are ‘using emotionally manipulative techniques’ and misinformation ‘in order to increase the […]
Some ‘Online Firsts’ and News
The following papers have been published at http://jfprhc.bmj.com/content/early/recent The financial costs to patients of diagnosing and excluding ectopic pregnancy (Unger et al) In their article, Unger and his colleagues in Edinburgh report on their assessment of an area of patient experience that is not often considered when assessing medical interventions. The financial impact on patients’ […]
Drugs – What’s in a name?
Branded, generics or branded generics? Do you know the difference? When a branded, or proprietary, drug comes ‘off patent’ it is common for other companies to apply for marketing authorisation and we are, increasingly, seeing this in sexual health. This can be for generic versions or for branded generics. Branded generics are simply generic equivalent […]
MedFASH celebrates 25 yrs
The Medical Foundation for HIV and Sexual Health is 25 yrs old (rebranded as MEDFASH). Established in 1987 by the BMA, as an independent foundation, with the aim of improving knowledge and understanding of HIV among health professionals it has grown and spread to encompass all aspects of sexual health. As part of this celebration […]